CALCIMEDICA, INC. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.48 USD | -1.26% |
|
-2.14% | +91.61% |
Valuation
| Fiscal Period: December | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|
| Capitalization 1 | 16.26 | 58.53 | - | - |
| Enterprise Value (EV) 1 | 16.26 | 58.53 | 58.53 | 58.53 |
| P/E ratio | -0.37 x | -3.15 x | -2.97 x | -3.25 x |
| Yield | - | - | - | - |
| Capitalization / Revenue | - | - | - | 20.9 x |
| EV / Revenue | - | - | - | 20.9 x |
| EV / EBITDA | -0.43 x | -2.46 x | -2.04 x | -2.08 x |
| EV / FCF | - | -1.89 x | -1.67 x | -1.36 x |
| FCF Yield | - | -53% | -59.8% | -73.5% |
| Price to Book | - | - | - | - |
| Nbr of stocks (in thousands) | 5,685 | 10,740 | - | - |
| Reference price 2 | 2.860 | 5.450 | 5.450 | 5.450 |
| Announcement Date | 3/28/24 | - | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| Net sales 1 | - | - | - | - | - | 2.8 |
| EBITDA 1 | - | - | -38.02 | -23.8 | -28.7 | -28.2 |
| EBIT 1 | - | - | -38.08 | -23.9 | -31.57 | -32.6 |
| Operating Margin | - | - | - | - | - | -1,164.29% |
| Earnings before Tax (EBT) 1 | - | - | -34.36 | -19 | -30.2 | -32.45 |
| Net income 1 | -23.5 | -14.51 | -34.36 | -19 | -30.2 | -32.45 |
| Net margin | - | - | - | - | - | -1,158.93% |
| EPS 2 | -8.650 | -5.080 | -7.660 | -1.730 | -1.837 | -1.675 |
| Free Cash Flow 1 | - | - | - | -31 | -35 | -43 |
| FCF margin | - | - | - | - | - | -1,535.71% |
| FCF Conversion (EBITDA) | - | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - |
| Announcement Date | 1/20/23 | 4/4/23 | 3/28/24 | - | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|
| Net sales 1 | - | - | - | - | - | - | - | - |
| EBITDA 1 | - | - | - | -4.3 | -5.752 | -5.5 | -6.7 | -5.9 |
| EBIT 1 | -22.34 | -6.583 | -4.833 | -4.319 | -5.767 | -7 | -5 | -5 |
| Operating Margin | - | - | - | - | - | - | - | - |
| Earnings before Tax (EBT) 1 | -19.29 | -6.304 | -4.619 | -4.146 | 0.13 | -5.567 | -6.433 | -6.2 |
| Net income 1 | -19.29 | -6.304 | -4.619 | -4.146 | 0.13 | -5.567 | -6.433 | -6.2 |
| Net margin | - | - | - | - | - | - | - | - |
| EPS 2 | -3.407 | -1.110 | -0.8200 | -0.2300 | 0.0100 | -0.5067 | -0.5467 | -0.4567 |
| Dividend per Share | - | - | - | - | - | - | - | - |
| Announcement Date | 5/12/23 | 8/10/23 | 11/9/23 | 3/28/24 | 5/13/24 | - | - | - |
1USD in Million2USD
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| Net Debt | - | - | - | - | - | - |
| Net Cash position | - | - | - | - | - | - |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - |
| Free Cash Flow 1 | - | - | - | -31 | -35 | -43 |
| ROE (net income / shareholders' equity) | - | - | - | - | - | - |
| ROA (Net income/ Total Assets) | - | - | - | - | - | - |
| Assets 1 | - | - | - | - | - | - |
| Book Value Per Share | - | - | - | - | - | - |
| Cash Flow per Share | - | - | - | - | - | - |
| Capex 1 | - | - | - | - | - | - |
| Capex / Sales | - | - | - | - | - | - |
| Announcement Date | 1/20/23 | 4/4/23 | 3/28/24 | - | - | - |
1USD in Million
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Sell
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
5.45
USD
Average target price
18.67
USD
Spread / Average Target
+242.51%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +91.61% | 58.53M | |
| +9.42% | 115B | |
| +11.84% | 106B | |
| -1.05% | 21.96B | |
| -14.15% | 21.84B | |
| -5.29% | 19.21B | |
| -4.16% | 18.08B | |
| -38.29% | 17.71B | |
| +7.99% | 14.32B | |
| +36.24% | 12.42B |
- Stock Market
- Equities
- CALC Stock
- Financials CalciMedica, Inc.
